FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

AbbVie Refresh P Recall

Refresh P

AbbVie Inc. · North Chicago, IL

Risk level
Class II
Reported by FDA
Oct 2, 2024
Recall ID
D-0664-2024
Check your lot numberHow we source this data

Summary

AbbVie recalled Refresh P starting Sep 16, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0664-2024 on Oct 2, 2024. Reason: Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.

Product description

Refresh P.M., (Mineral Oil 42.5%, White Petrolatum 57.3%) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distributed by: Allergen, an AbbVie company, Madison, NJ 07940, UPC code: 300230667043,

Lot numbers, UPCs & expiration codes

Lot: 387392, 387393, 387394, Exp. Feb 25; 387395, 388729, 388730, 388731, 388732, 390391, 390404, Exp. Apr 25; 391688, 391734, Exp. Oct 25; 392616, 392620, Exp. Dec 25; 392987, 393560, Exp. Jan 26; 394816, 394821, Exp. Nov 25; 394927, 394929, Exp. Feb 26; 395713, 395992, 396815, Exp. Mar 26; 396816, 397248, 397315, Exp. Apr 26; 397316, 397774, 397775, 397776, 398436, 398437, Exp. May 26; 398621, 398643, 398739, 398944, 399001, 399255, 399270, 399271, Exp. Jun 26; 399798, 399806, 400003, Exp. Jul 26; 408668, 408723, 408737, 408853, 408895, Exp. Apr 27; 409121, 409142, Exp. May 27; 409261, Exp. Apr 27; T4534, T4535, T4591, T4592, Exp. Dec 24; T4660, T4661, T4696, T4697, T4709, T4772, T4773, Exp. Jan 25; T4844, T4845, Feb 25

Where it was sold

Nationwide in the USA, Foreign Consignees (Austrailia, Canada, Great Britain)

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0664-2024
Classification
Class II
Status
Ongoing
Recall initiated
Sep 16, 2024
FDA report date
Oct 2, 2024
Quantity
2,473,563 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
AbbVie Inc.

Original FDA data

Every field from FDA enforcement report D-0664-2024, exactly as published.

Show all FDA fields
City
North Chicago
State
IL
Status
Ongoing
Country
United States
Event ID
95332
Address
1 N Waukegan Rd
Code information
Lot: 387392, 387393, 387394, Exp. Feb 25; 387395, 388729, 388730, 388731, 388732, 390391, 390404, Exp. Apr 25; 391688, 391734, Exp. Oct 25; 392616, 392620, Exp. Dec 25; 392987, 393560, Exp. Jan 26; 394816, 394821, Exp. Nov 25; 394927, 394929, Exp. Feb 26; 395713, 395992, 396815, Exp. Mar 26; 396816, 397248, 397315, Exp. Apr 26; 397316, 397774, 397775, 397776, 398436, 398437, Exp. May 26; 398621, 398643, 398739, 398944, 399001, 399255, 399270, 399271, Exp. Jun 26; 399798, 399806, 400003, Exp. Jul 26; 408668, 408723, 408737, 408853, 408895, Exp. Apr 27; 409121, 409142, Exp. May 27; 409261, Exp. Apr 27; T4534, T4535, T4591, T4592, Exp. Dec 24; T4660, T4661, T4696, T4697, T4709, T4772, T4773, Exp. Jan 25; T4844, T4845, Feb 25
Postal code
60064-1802
Report date
Oct 2, 2024
Product type
Drugs
Recall number
D-0664-2024
Classification
Class II
Recalling firm
AbbVie Inc.
Product quantity
2,473,563 tubes
Reason for recall
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Refresh P.M., (Mineral Oil 42.5%, White Petrolatum 57.3%) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distributed by: Allergen, an AbbVie company, Madison, NJ 07940, UPC code: 300230667043,
Distribution pattern
Nationwide in the USA, Foreign Consignees (Austrailia, Canada, Great Britain)
Recall initiation date
Sep 16, 2024
Initial firm notification
Letter
Center classification date
Sep 23, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0664-2024, published Oct 2, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls